Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Long-Term Deferred Tax (2023 - 2025)

Outset Medical (OM) has disclosed Long-Term Deferred Tax for 3 consecutive years, with $260.6 million as the latest value for Q4 2025.

  • Quarterly Long-Term Deferred Tax rose 26221.41% to $260.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $260.6 million through Dec 2025, up 26221.41% year-over-year, with the annual reading at $260.6 million for FY2025, 26221.41% up from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $260.6 million at Outset Medical, up from $990000.0 in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $260.6 million in Q4 2025, with the low at $990000.0 in Q4 2024.
  • Average Long-Term Deferred Tax over 3 years is $161.7 million, with a median of $223.4 million recorded in 2023.
  • The sharpest move saw Long-Term Deferred Tax tumbled 99.56% in 2024, then soared 26221.41% in 2025.
  • Over 3 years, Long-Term Deferred Tax stood at $223.4 million in 2023, then crashed by 99.56% to $990000.0 in 2024, then skyrocketed by 26221.41% to $260.6 million in 2025.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $260.6 million, $990000.0, and $223.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.